This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ZIKAVAC (Inactivated Virus)

Bharat Biotech

Drug Names(s): Zika Vaccine, ZIKAVAC

Description: Bharat Biotech is developing ZIKAVAC, a Zika vaccine, using inactivated virus.

ZIKAVAC (Inactivated Virus) News

Scrip Atriva: Targeting Patients, Not Virus, Is The Way Forward In Flu

Scrip Tech Transfer Roundup: Mustang, Nationwide Children’s Hospital Collaborate In Pediatric Glioblastoma

Pink Sheet First Ebola Multi-Drug Trial Starts In DRC

Scrip Doubling Up On Vaccines: A Combined Zika And Dengue Vaccine May Be Possible

Additional information available to subscribers only:

Targets
Routes
Catalysts
Designations
Events

Request a Free Demo Subscriber Login Search for another drug